| 23rd week of 2014 patent applcation highlights part 54 |
| Patent application number | Title | Published |
|---|
| 20140155460 | MICRO-RNA'S THAT REGULATE MUSCLE CELLS - The present invention describes microRNAs that regulate the differentiation, proliferation and death of cardiac and skeletal muscles cells. These molecules represent unique targets in the developmental pathways of muscle cells. They also can be used as active agents to induce differentiation in progenitor cells, and their down-regulation permits the maintenance and expansion of progenitor cell populations. | 2014-06-05 |
| 20140155461 | MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF BONE AND JOINT DEGENERATIVE DISEASES - The present invention relates to methods for identifying agents capable of inhibiting the expression or activity of proteins involved in the processes modulating osteoclastogenesis, which inhibition is useful in the prevention and/or treatment of bone and joint degenerative diseases and diseases involving aberrant activity or differentiation of osteoclasts. In particular, the present invention provides methods for identifying agents for use in the prevention and/or treatment of rheumatoid arthritis. | 2014-06-05 |
| 20140155462 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITIONS OF EGFR BY DOUBLE-STRANDED RNA - This invention relates to compounds, compositions, and methods useful for reducing EGFR target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents. | 2014-06-05 |
| 20140155463 | SPINAL MUSCULAR ATROPHY TREATMENT VIA TARGETING SMN2 CATALYTIC CORE - The present invention is directed to methods and compositions for blocking the effect of the intronic inhibitory splicing region of intron 7 of the SMN2 gene. The compositions and methods of the instant invention include short oligonucleotide reagents (e.g., oligoribonucleotides) that effectively target sites in the SMN2 pre-mRNA, thereby modulating the splicing of SMN2 pre-mRNA to include exon 7 in the processed transcript. The short target regions are 8-mers and 5-mers and also include the identification of a single nucleotide base that is essential for initiating a long distance stearic inhibitory interactions as well as novel targets distant from intron 7 which block the intronic inhibitory splicing of the same. These short target regions and concomitant inhibitory blocking oligonucleotides are less expensive and easier to manufacture and are small enough to cross the blood brain barrier. | 2014-06-05 |
| 20140155464 | TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Tristetraproline (TTP), in particular, by targeting natural antisense polynucleotides of Tristetraproline (TTP). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of TTP. | 2014-06-05 |
| 20140155465 | DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS - Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds. | 2014-06-05 |
| 20140155466 | USE OF APTAMERS IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASES - The present invention is directed to an aptamer comprising or consisting of the nucleic acid sequence of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and/or a nucleic acid sequence being at least 80% identical to one of SEQ ID No. 1, 2 and 3 for use in therapy and/or diagnosis of autoimmune diseases, wherein the autoimmune disease is cardiomyopathy, dilated cardiomyopathy (DCM), peripartum cardiomyopathy (PPCM), idiopathic cardiomyopathy, Chagas' cardiomyopathy, Chagas' megacolon, Chagas' megaesophagus, Chagas' neuropathy, benign prostatic hyperplasia, scleroderma, psoriasis, Raynaud syndrome, pre-eclamsia, kidney allograft rejection, myocarditis, glaucoma, hypertension, pulmonary hypertension, malignant hypertension, and/or Alzheimer's disease. | 2014-06-05 |
| 20140155467 | PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS - Isolated polynucleotide sequences exhibiting endothelial cell specific promoter activity, novel cis regulatory elements and methods of use thereof enabling treatment of diseases characterized by aberrant neovascularization or cell growth are disclosed. | 2014-06-05 |
| 20140155468 | METHODS AND COMPOSITIONS FOR REGULATION OF METABOLIC DISORDERS - Cells and methods of using these cells for expressing a transgene expressing a protein that is aberrantly expressed in a metabolic disorders from a safe harbor locus. | 2014-06-05 |
| 20140155469 | ADENO-ASSOCIATED-VIRUS REP SEQUENCES, VECTORS AND VIRUSES - The invention provides adeno-associated virus (AAV) replication (Rep) sequences. In one embodiment, the invention provides nucleotide sequences encoding a chimeric protein, wherein the encoded chimeric protein contains a wild type AAV Rep inhibitory amino acid sequence, and wherein the nucleotide sequences contain a scrambled and/or deoptimized polynucleotide sequence encoding the wild type AAV Rep inhibitory amino acid sequence. The invention provides vectors, cells, and viruses containing the invention's sequences. Also provided are methods for detecting portions of the AAV Rep inhibitory amino acid sequence, which reduce replication and/or infection and/or productive infection by viruses. The invention's compositions and methods are useful for site-specific integration and/or expression of heterologous sequences by recombinant adeno-associated virus (rAAV) vectors and by rAAV virus particles, such as hybrid viruses (e.g., Ad-AAV) comprising such vectors. The invention's compositions and methods find application in, for example, gene therapy and/or vaccines. | 2014-06-05 |
| 20140155470 | PLA2R1 AS ANTI-TUMORAL COMPOUND AND AS BIOMARKER FOR THE DETECTION OF CANCER - Compositions comprising a polynucleotide of human PLA2R1, a polypeptide of human PLA2R1 or an extracellular fragment of human PLA2R1 for use in the treatment of cancer in particular breast cancer, pancreatic cancer, colorectal cancer, kidney cancer and melanoma. | 2014-06-05 |
| 20140155471 | TREATING NEUROLOGICAL DISEASE OR INJURY WITH A DYNAMIN-RELATED PROTEIN 1 (DRP1) ENCODING NUCLEIC ACID - Provided herein are methods of treating a neurological disease or injury in a subject comprising administering to the subject a recombinant adeno-associated virus (rAAV) vector comprising a DRP1-encoding nucleic acid, wherein the DRP1 encoded by the nucleic acid comprises a mutation compared to wild-type DRP1. | 2014-06-05 |
| 20140155472 | MODIFIED POLYNUCLEOTIDES FOR TREATING ARGININOSUCCINATE SYNTHASE 1 PROTEIN DEFICIENCY - The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. | 2014-06-05 |
| 20140155473 | MODIFIED GLUCOSIDASE, BETA, ACID POLYNUCLEOTIDES FOR TREATING PROTEIN DEFICIENCY - The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. | 2014-06-05 |
| 20140155474 | MODIFIED POLYNUCLEOTIDES FOR TREATING CYSTIC FIBROSIS - The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. | 2014-06-05 |
| 20140155475 | MODIFIED POLYNUCLEOTIDES FOR TREATING LIPASE A, LYSOSOMAL ACID, CHOLESTEROL ESTERASE PROTEIN DEFICIENCY - The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. | 2014-06-05 |
| 20140155476 | SIMIAN SUBFAMILY E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 AND USES THEREOF - A recombinant vector comprises simian adenovirus SAdV-39, -25.2, -26, -30, -37, and -38 sequences and a heterologous gene under the control of regulatory sequences. A cell line which expresses simian adenovirus SAdV-39, -25.2, -26, -30, -37, and -383 gene(s) is also disclosed. Methods of using the vectors and cell lines are provided. | 2014-06-05 |
| 20140155477 | SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF - Provided herein are substituted biaryl sulfonamide compounds, pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or amelioration of various disorders, including cancer and proliferative disorders. In one embodiment, the compounds provided herein modulate initiation of protein translation. In one embodiment, the compounds provided herein are used in combination with surgery, radiation therapy, immuno therapy and/or one or more additional anticancer drugs for the treatment, prevention, and/or amelioration of cancer and proliferative disorders. | 2014-06-05 |
| 20140155478 | ANTIFUNGAL COMPOUND AND USES THEREOF - Disclosed herein is a novel antifungal compound, derivatives that are used to treat fungal infections. In a specific embodiment, the compound is a small molecule. In a specific embodiment, the compound described herein inhibits yeast to hypha transition under robust hyphal inducing conditions at lower concentration of the molecule. Also disclosed is a composition comprising the antifungal compound. In a specific embodiment, the composition is a pharmaceutical composition. Also disclosed is a method of treating and/or preventing fungal infection using the disclosed compound. The disclosed compound exhibits antifungal activity against wide range of fungal species at slightly higher concentrations. Antifungal compound disclosed herein is used as anti-biofilm agent against fungal infections. | 2014-06-05 |
| 20140155479 | TIGLIEN-3-ONE DERIVATIVES - The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment. | 2014-06-05 |
| 20140155480 | Scyllo-Inositol Derivatives and Their Use in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation of Amyloid Formation, Deposition, Accumulation for Persistence - Scyllo-Inositol derivatives represented by structural formula II are described, wherein at least one and not more than five of R | 2014-06-05 |
| 20140155481 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 2014-06-05 |
| 20140155482 | FLUID COMPOSITIONS THAT CAN FORM A COATING HAVING ANTIVIRAL PROPERTIES - The aim of the present invention is to provide a fluid composition that can form a coating, said composition being characterized in that it contains, at least in a solvent medium, an effective amount of at least one natural virucide selected from among lauric acid, monolaurin, lactoferrin and essential oils having antiviral activity and/or one of the precursors thereof, said composition having a viscosity of 30 mPa·s to 40 Pa·s at room temperature and pressure. | 2014-06-05 |
| 20140155483 | Edible Oral Strip or Wafer Dosage Form Containing Ion Exchange Resin for Taste Masking - An edible oral film strip dosage form containing an unpalatable acidic active pharmaceutical ingredient, particularly ketoprofen, and an ion exchange resin as a primary taste masking agent, along with an optional alkaline agent and further optionally containing one or more secondary taste masking agents is provided. The edible oral film strip dosage matrix is formed from at least one water soluble or miscible polymer(s). The optional secondary taste masking ingredients include one or more of flavoring agent(s), sweetener(s), cooling sensation agent(s), and taste receptor blocker(s). The inventive dosages minimize or completely mask the bitterness, burning sensation and throat irritation associated with many acidic active pharmaceutical ingredients. Methods for preparing the inventive edible oral film strip dosage forms are disclosed, as well as their method of administration. | 2014-06-05 |
| 20140155484 | METHOD OF TREATING LIVER DISORDERS - A compound of Formula (I): | 2014-06-05 |
| 20140155485 | Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases - The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions. | 2014-06-05 |
| 20140155486 | Administration of Iloprost as Aerosol Bolus - The present invention relates to novel methods, compositions and kits useful for the treatment of pulmonary diseases such as pulmonary arterial hypertension. In particular, aerosolisable compositions of iloprost are provided which are for use in inhalation therapy. Their administration is by bolus inhalation, which is patient-friendly, effective, and well tolerated. Bolus inhalation may, for example, be achieved using an efficient nebuliser based on the vibrating mesh technology. | 2014-06-05 |
| 20140155487 | METHOD FOR CORRECTING A LIPID IMBALANCE IN A SUBJECT - The present invention relates to methods for the treatment of a disease or condition associated with lipid imbalance using fenretinide. The invention also relates to diagnostic and screening methods based on the determination of lipid levels. | 2014-06-05 |
| 20140155488 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH - Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I | 2014-06-05 |
| 20140155489 | PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM - The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a binder with a breaking strength of ≧500 N, by exposing a mixture comprising the active ingredient and the binder to ultrasound and force. | 2014-06-05 |
| 20140155490 | THERAPEUTIC COMPOUNDS - The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs. | 2014-06-05 |
| 20140155491 | Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof - A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier does not include petrolatum or ethanol. | 2014-06-05 |
| 20140155492 | COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS - A composition and method for enhancing fertility of a male or female human by affecting levels of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol in the human. The composition comprises effective amounts of spermine and spermidine, administered at least once daily for a period of at least thirty days. | 2014-06-05 |
| 20140155493 | BIS-AROMATIC ANTICANCER AGENTS - Treatment of cancer includes administering a compound of formula (I) to a subject. In particular, treatment of colorectal cancer is described. | 2014-06-05 |
| 20140155494 | TRI-MOLECULAR COMPLEXES AND THEIR USE IN DRUG DELIVERY SYSTEMS - This invention relates to macromolecular complexes useful in drug delivery systems, specifically tri-molecular complexes made between a water-soluble polymer and an acid-insoluble polymer in presence of a bridging molecule. In one aspect, the invention relates to a tri-molecular complex comprising gelatin, acrylic acid/methacrylic acid copolymers, and arginine for use in a soft capsule dosage form. In another aspect, the invention is directed to a tri-molecular complex a hydrophilic, film-forming, water-soluble polymer, a second water-soluble polymer, and a bridging molecule, wherein the second water-soluble polymer is less water-soluble than the hydrophilic, film-forming, water-soluble polymer. | 2014-06-05 |
| 20140155495 | TRANSDERMAL DELIVERY PATCH - A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier. | 2014-06-05 |
| 20140155496 | Templated Native Silk Smectic Gels - One aspect of the present invention relates to a method of preparing a fibrous protein smectic hydrogel by way of a solvent templating process, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; and collecting the resulting fibrous protein smectic hydrogel and allowing it to dry. Another aspect of the present invention relates to a method of obtaining predominantly one enantiomer from a racemic mixture, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; allowing the enantiomers of racemic mixture to diffuse selectively into the smectic hydrogel in solution; removing the smectic hydrogel from the solution; rinsing predominantly one enantiomer from the surface of the smectic hydrogel; and extracting predominantly one enantiomer from the interior of the smectic hydrogel. The present invention also relates to a smectic hydrogel prepared according to an aforementioned method. | 2014-06-05 |
| 20140155497 | HEPAROSAN-BASED BIOMATERIALS AND COATINGS AND METHODS OF PRODUCTION AND USE THEREOF - Biomaterial compositions that include an isolated heparosan polymer are disclosed, as well as kits containing such biomaterial compositions and methods of producing and using such biomaterial compositions. | 2014-06-05 |
| 20140155498 | Method of Manufacture of Stable Liquid Coagulation Factors - A diagnostic or therapeutic formulation of stable liquid coagulation factors comprises at least one coagulation factor, at least one stabilizer, and optional additives. The stabilizer is either amylopectin, galatomannan polysaccharide, agarose, agaropectin, and gelatin, or a blend of amylopectin, galatomannan polysaccharide, agarose, agaropectin, and gelatin. A preferred additive is the zwitterionic buffer 3-[N-tris(hydroxymethyl)methylamino)-2-hydroxypropane sulfonic acid (TAPSO). The stable liquid coagulation factors can be used as reagents and controls in plasma clotting assays. In addition the therapeutic formulation can be used for factor replacement therapy. The stable liquid clotting factors are made by combining the coagulation factor(s), stabilizer(s), and additive(s) in a liquid carrier and sterilizing the mixture. Coagulation factors can be concentrated by selective precipitation from plasma. In addition, the clotting activity of the formulation can be adjusted by adding a factor concentrate to a less concentrated formulation. | 2014-06-05 |
| 20140155499 | BIOMARKERS OF OSTEOARTHRITIS - Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) and determining treatment are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, Apolipoprotein A1, and Apolipoprotein E. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described. | 2014-06-05 |
| 20140155500 | INJECTION OF ADDITIVE INTO A UNIT FOR SYNTHESISING HYDROCARBONS STARTING FROM SYNTHESIS GAS ENABLING A HOMOGENOUS CONCENTRATION OF CATALYST TO BE CONTROLLED AND MAINTAINED - The invention relates to a process for synthesising hydrocarbons starting from a feedstock containing synthesis gas. In the process a solid Fischer-Tropsch catalyst is employed in a three-phase reaction section operated so that the catalyst is maintained in suspension in a liquid phase by the circulation of a gaseous phase from the bottom to the top of the reaction section. The process utilizes conditions to control and maintain the homogeneity of the concentration of catalyst particles in the reaction section. | 2014-06-05 |
| 20140155501 | PROCESS FOR PREPARING A COBALT - CONTAINING FISCHER TROPSCH CATALYST - A process for preparing a cobalt-containing hydrocarbon synthesis catalyst includes calcining an initial catalyst precursor comprising a catalyst support supporting a cobalt compound, by heat treating the initial catalyst precursor under non-reducing conditions in order to decompose the cobalt compound and/or to cause the cobalt compound to react with oxygen, thereby to obtain a calcined initial catalyst precursor. A cobalt compound is introduced onto and/or into the calcined initial catalyst precursor so that the calcined initial catalyst precursor supports this cobalt compound thereby obtaining a subsequent catalyst precursor. The subsequent catalyst precursor is directly subjected to reduction conditions to activate the subsequent catalyst precursor, thereby to obtain a cobalt-containing hydrocarbon synthesis catalyst. | 2014-06-05 |
| 20140155502 | FUNCTIONALIZED MAIN CHAIN POLYMERS - A non crosslinked, covalently crosslinked and/or conically crosslinked polymer, having repeating units of the general formula (1) | 2014-06-05 |
| 20140155503 | Closed-Loop Recycled Polyurethane Foam, Methods Of Manufacture and Products Therefrom - The present disclosure relates to the production of molded products containing recycled content, and more particularly polyurethane foam which includes polyol recovered from chemical recycling of polyurethane foam scrap, which polyol has been treated to optimize viscosity and/or reactivity characteristics. | 2014-06-05 |
| 20140155504 | EXTRUSION OF POLYURETHANE COMPOSITE MATERIALS - Methods of extruding polyurethane composite materials are described. One method includes introducing at least one polyol and inorganic filler to a first conveying section of the extruder, transferring the at least one polyol and inorganic filler to a first mixing section of an extruder, mixing the at least one polyol and the inorganic filler in the first mixing section, transferring the mixed at least one polyol and inorganic filler to a second conveying section of the extruder, introducing a di- or poly-isocyanate to the second conveying section, transferring the mixed at least one polyol and inorganic filler and the di- or poly-isocyanate to a second mixing section, mixing the mixed at least one polyol and inorganic filler with the di- or poly-isocyanate in the second mixing section of the extruder to provide a composite mixture, and transferring the composite mixture to an output end of the extruder. Other related methods are also described. | 2014-06-05 |
| 20140155505 | PROCESS FOR PHYSICALLY FOAMING A MASTERBATCH - The invention is directed to a masterbatch comprising | 2014-06-05 |
| 20140155506 | COMPOSITION FOR POLYURETHANE FOAM, PREPARATION FOR POLYURETHANE FOAM, POLYMER POLYOL PREPARATION FOR POLYURETHANE FOAM, PRODUCTION PROCESSES THEREFOR, AND POLYURETHANE FOAM - The present invention relates to a preparation for a polyurethane foam and a polymer polyol preparation for a polyurethane foam, each of which exhibits high coloration and discoloration inhibition properties over a long period of time when stored, and to a composition for a polyurethane foam, which is excellent in storage stability and is preferable as a resin premix. The composition for a polyurethane foam of the present invention is characterized by comprising (i) at least one polyol selected from a polyoxyalkylene polyol and a polymer polyol wherein polymer fine particles obtained by polymerizing a compound having an unsaturated bond are dispersed in the polyoxyalkylene polyol, (ii) a compound having a P═N bond, (iii) an antioxidant having a hydroxyphenyl group, (iv) at least one acid selected from the group consisting of an acyclic aliphatic monocarboxylic acid of 2 to 25 carbon atoms, a hydroxycarboxylic acid of 2 to 25 carbon atoms, a polycarboxylic acid of 20 to 60 carbon atoms, a specific aromatic monocarboxylic acid, a sulfonic acid and an acid having a sulfuric acid ester group, or its salt, (v) a catalyst for polyurethane foam production and (vi) a blowing agent. | 2014-06-05 |
| 20140155507 | RESIN FOAM AND PROCESS FOR PRODUCING THE SAME - Provided is a resin foam that is satisfactorily flexible and highly resistant to heat, exhibits superior strain recoverability at high temperatures, and has a high instantaneous recovery rate. This resin foam is formed from a resin composition containing an acrylic polymer, an active-energy-ray-curable compound having two (meth)acryloyl groups per molecule, an active-energy-ray-curable compound having three or more (meth)acryloyl groups per molecule, and a thermal crosslinking agent. The active-energy-ray-curable compound having two (meth)acryloyl groups per molecule and the active-energy-ray-curable compound having three or more (meth)acryloyl groups per molecule are preferably contained in a total content of from 20 to 150 parts by weight per 100 parts by weight of the acrylic polymer. | 2014-06-05 |
| 20140155508 | Polyimide Powder and Porous Polyimide Body Using the Same - A porous polyimide is obtained by pulverizing a foam product of a polyimide precursor. Particularly, the foam product of the polyimide precursor is a product of heating the polyimide precursor for foaming with microwave radiation and has the imidization ratio of 10 to 90%, and is preferably a foam product including a tetracarboxylic acid component, which contains 50 mol % or more of biphenyltetracarboxylic acids and is monoesterified and/or diesterified in parts with a lower aliphatic primary alcohol with the number of carbon atoms of 4 or less, and a diamine component containing 90 mol % or more of an aromatic diamine, and being a monomer salt of which the ratio of the tetracarboxylic acid component and the diamine component is approximately 2:1 and in a solid form dispersed at molecular level. | 2014-06-05 |
| 20140155509 | POLYOL COMPOSITION FOR RIGID POLYURETHANE FOAM AND PRODUCTION METHOD FOR RIGID POLYURETHANE FOAM - A polyol composition for a rigid polyurethane foam, which comprises polyol compounds, and water as a blowing agent, and which is mixed with a polyisocyanate component to react therewith, and thereby forming the rigid polyurethane foam, wherein the polyol compounds comprise a polyether polyol (A) which is a polymer made from an alkylene oxide and has an average functional group number of 2 to 4 and a weight-average molecular weight of 3000 to 8000, and a short glycol (B) having a molecular weight less than 250, and the water is contained in an amount of 20 to 100 parts by weight for 100 parts by weight of the polyol compounds. | 2014-06-05 |
| 20140155510 | SURFACE-MODIFIED ELASTIC BODY - Provided are surface-modified elastic bodies (e.g. gasket for syringes) each obtained by a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer, the method being capable of providing surfaces with excellent properties such as excellent sliding properties, excellent durability against repeated sliding motion, and excellent performance in preventing adsorption and aggregation of proteins, and allowing the surfaces to maintain the sealing properties, without using expensive self-lubricating plastics. The invention relates to surface-modified elastic bodies (e.g. gasket for syringes) at least partially having a surface modified by a surface modification method including: step 1 of forming polymerization initiation points on a surface of an object to be modified that includes a rubber vulcanizate or thermoplastic elastomer, and step 2 of radically polymerizing a monomer containing a C—N bond in a molecule thereof, starting from the polymerization initiation points, to grow polymer chains on the surface of the object. | 2014-06-05 |
| 20140155511 | SULFUR CHELATED RUTHENIUM COMPOUNDS USEFUL AS OLEFIN METATHESIS CATALYSTS - Sulfur chelated ruthenium compounds represented by the following formula: | 2014-06-05 |
| 20140155512 | Control Over Controlled Radical Polymerization Processes - A procedure for improved temperature control in controlled radical polymerization processes is disclosed. The procedure is directed at controlling the concentration of the persistent radical in ATRP and NMP polymerizations procedures and the concentration of radicals in a RAFT polymerization process by feeding a reducing agent or radical precursor continuously or intermittently to the reaction medium through one of more ports. | 2014-06-05 |
| 20140155513 | Methods of Forming Compositions and Articles - A method for forming a composition comprising a propylene-based polymer and a co-agent is provided. The method comprises introducing a propylene-based polymer to an extruder and introducing the co-agent to the extruder at a position within the extruder where the temperature is from 23° C. to 125° C. | 2014-06-05 |
| 20140155514 | DRIER FOR ALKYD RESIN COMPOSITIONS - The invention relates to an alkyd resin composition comprising components: (A) at least an auto-oxidisable alkyd resin component comprising unsaturated fatty acid or its derivative, selected from: (i) alpha, beta-unsaturated ester-functional alkyd resin; (ii) combination of a alpha, beta-unsaturated ester functional material and an alkyd resin; and (iii) mixture of components (i) and (ii); Wherein the alkyd has an oil length of at least 20% unsaturated fatty acids; (B) a daylight photoinitiator; (C) a metal drier; and (D) optionally a liquid medium selected from the group consisting of an organic solvent, water, non-volatile diluent and mixtures thereof; wherein if the liquid medium is present and is: a) substantially based on organic solvent and/or diluent then the VOC is <300 g/l, or b) substantially based on water then the VOC is <100 g/l. | 2014-06-05 |
| 20140155515 | SILICONE HYDROGEL COMPOSITION AND SILICONE HYDROGEL CONTACT LENSES MADE FROM THE COMPOSITION - A silicone hydrogel composition is disclosed. The composition includes at least one silicone macromer, a hydroxy-functionalized silicone-containing monomer, a first hydrophibic monomer and at least one crosslinker, in which the first hydrophibic monomer is N-vinyl pyrrolidone. The silicone macromer and the hydroxy-functionalized silicone-containing monomer are mutually soluble with N-vinylpyrrolidone. Silicone hydrogel contact lenses prepared from the silicone hydrogel composition are also disclosed. | 2014-06-05 |
| 20140155516 | POLY (DIOL CO-CITRATE) HYDROXYAPATITE COMPOSITE FOR TISSUE ENGINEERING AND ORTHOPAEDIC FIXATION DEVICES - The present invention is directed to a novel poly(diol citrates)-based bioceramic composite materials created using completely biodegradable and a bioceramic material polymers that may be used in implantable devices. More specifically, the specification describes methods and compositions for making and using bioceramic composites comprised of citric acid copolymers and a bioceramic material. | 2014-06-05 |
| 20140155517 | UV Barrier Film - Transparent polypropylene film comprising at least two UV-absorbing additives, a first additive being a non-aggregated inorganic material present in the film composition in an amount of from 0.1 to 5.0% by weight, and a second additive comprising an organic material selected from triazines, hindered amines, oxanilides, cyanoacrylates, benzotriazoles and/or benzophenones and present in the film in an amount of less than 2.0% by weight and wherein when both benzotriazole(s) and benzophenone(s) are present in the film, the ratio of benzotriazole(s) to benzophenone(s) is above 0.5. | 2014-06-05 |
| 20140155518 | RUBBER MIXTURES CONTAINING SILICIC ACID AND SULFUR-CONTAINING ADDITIVES - The present invention relates to silica-containing rubber mixture produced from at least one rubber, from a sulphur-containing alkoxysilane, from a crosslinking agent, from a filler, and optionally from further rubber auxiliaries, where the said mixture comprises from 0.1 to 15 parts by weight, based on 100 parts by weight of rubber used, of a silicon-free polysulphide additive of the formula (I) | 2014-06-05 |
| 20140155519 | TIRE WITH A TREAD COMPRISING AN EMULSION SBR HAVING A HIGH TRANS CONTENT - The present invention relates to a tyre, the tread of which comprises a rubber composition comprising at least:
| 2014-06-05 |
| 20140155520 | RUBBER COMPOSITION FOR USE IN TIRES - A rubber composition comprises from 2 to 50 parts by weight of an aromatic modified terpene resin having a softening point of ≧100° C., and two types of silica, a silica X and a silica Y, at a total quantity of 60 to 130 parts by weight relative to 100 parts by weight of a diene rubber containing from 5 to 50 weight % of a modified S-SBR having a vinyl content of not lower than 60 weight %. A functional group in the modified S-SBR reacts with a silanol group, a proportion of silica relative to the total quantity of a reinforcing filler containing the silica and carbon black is not lower than 85 weight %, a nitrogen specific surface area of the silica X is not lower than 140 m | 2014-06-05 |
| 20140155521 | RUBBER COMPOSITION FOR TIRES AND PNEUMATIC TIRE - The present invention provides a rubber composition for tires capable of improving handling stability, fuel economy, wet grip performance, elongation at break, and abrasion resistance together while maintaining the balance between them. The present invention also provides a pneumatic tire including the rubber composition. The present invention relates to a rubber composition for tires containing a diene rubber, silica having a BET specific surface area of 170 to 270 m | 2014-06-05 |
| 20140155522 | DURABLE SUPERHYDROPHOBIC COATINGS - A superhydrophobic coating including a plurality of particles and a resin. The particles covalently bond to the resin and the resin does not fill the pores of the superhydrophobic particles such that the three dimensional surface topology of the superhydrophobic particles is preserved. | 2014-06-05 |
| 20140155523 | SYNTHETIC RAW ELASTOMERIC COMPOSITIONS IN FREE-FLOWING PELLET FORM AND PROCESS FOR OBTAINING THE SAME - A raw elastomeric composition in free-flowing pellet form is described, which comprises a raw elastomer with molecular weight from 50,000 to 400,000 Da, and an anti-block agent comprising inorganic fillers, capable of forming emulsions in water. Likewise, a process for obtaining said raw elastomeric compositions in free-flowing pellet form, comprising the steps of: a) polymerizing at least one monomer through solution polymerization in order to obtain elastomer crumb; b) forming an aqueous suspension of the elastomer crumbs; c) dewatering the aqueous suspension; d) adding an anti-block agent comprising inorganic fillers capable of forming emulsions in water; e) drying the dewatered suspension; and f) pelletizing the elastomer to form a raw elastomeric composition in free-flowing pellets form. The raw elastomeric composition in free-flowing pellets form thus obtained can be used as an adhesive composition, in asphalt modification and in asphalt emulsions. | 2014-06-05 |
| 20140155524 | RUBBER COMPOSITION AND PNEUMATIC TIRE - A rubber composition contains diene-based rubber, silica, a sulfur-containing silane coupling agent, and an amine compound. The amine compound is indole, indigo, and derivatives thereof each of which is represented by a predetermined formula. The content of the silica is 20 to 120 parts by mass based on 100 parts by mass of the diene-based rubber. The content of the sulfur-containing silane coupling agent is 3 to 15 parts by mass based on 100 parts by mass of the silica. The content of the amine compound is 0.5 to 20 parts by mass based on 100 parts by mass of the silica. By the use of the rubber composition with this composition, a tire having improved dispersibility of silica, excellent wet performance, and excellent rolling resistance and showing a suppressed decrease in reinforcing property can be produced. | 2014-06-05 |
| 20140155525 | LIQUID HARDENING - Curing agents for air-drying alkyd-based resins, coatings, such as paint, varnish or wood stain, inks and linoleum floor coverings, based on an iron/manganese complex containing tetradentate, pentadentate or hexadentate nitrogen donor ligands are disclosed. | 2014-06-05 |
| 20140155526 | POLYIMIDE COMPOSITION VARNISH, FILM USING THE SAME, AND METHOD OF MANUFACTURING THE POLYIMIDE COMPOSITION VARNISH - A polyimide composition varnish, a film prepared from the same, and a method of manufacturing a polyimide composition varnish, the polyimide composition varnish including a polyimide or a polyimide precursor; and an organically modified layered silicate in which interlayer ions are replaced with organic phosphonium ions. | 2014-06-05 |
| 20140155527 | FLAME RETARDANT POLYOLEFIN COMPOSITION FOR SHIPPING PALLETS - There is provided herein a flame retarded polyolefin composition comprising a thermoplastic polyolefin polymer, an inorganic flame retardant and a synergist comprising a metal phosphonate represented by the formula: | 2014-06-05 |
| 20140155528 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED PRODUCT MADE THEREOF - A thermoplastic resin composition includes 100 parts by weight of a thermoplastic resin including a polylactic acid resin (A); 10 to 50 parts by weight of a flame retardant (B); and 1 to 20 parts by weight of low melting point glass powder (C) having a median diameter (D50) in particle size distribution measurement of not greater than 6 μm and a softening temperature of not higher than 600° C. | 2014-06-05 |
| 20140155529 | FORMALDEHYDE-FREE BINDER COMPOSITIONS FOR FIBROUS MATERIAL - Compositions for binding organic or inorganic fibers is described. The compositions may include an aqueous solution having a pH of about 4.5 or more. The aqueous solution may include a polycarboxy polymer that is about 10%, by wt., to 100%, by wt., of a butenedioic acid or butenedioic anhydride; and a polyol. The compositions can maintain a pH of about 5 or more after being cured into a thermoset plastic with the fibers. Processes for preparing a binder composition for organic or inorganic fibers are also described. The processes may include providing an aqueous solution of polycarboxylic acid polymers, where the polymers comprise about 10%, by wt., to 100%, by wt., of a butenedioic acid or butenedioic anhydride; adding a polyol to the aqueous solution; and maintaining the pH of the aqueous solution at about 5 or more. | 2014-06-05 |
| 20140155530 | FOULING-RESISTANT COMPOSITION COMPRISING STEROLS AND/OR DERIVATIVES THEREOF - The present invention provides a fouling-resistant composition which comprises an elastomer and a component comprising sterol(s) and/or sterol derivative(s), wherein the component is selected from acylated lanolin, alkoxylated lanolin, or lanolin oil, or a composition comprising at least 20 weight % of one or more sterol(s), at least 20 weight % of one or more C | 2014-06-05 |
| 20140155531 | PREPARATION OF ANTIPLASTICIZERS FOR THERMOPLASTIC POLYESTERS - A process for making bis(aryloxyalkyl)terephthalates useful as antiplasticizers for thermoplastic polyesters is disclosed. Dimethyl terephthalate is reacted with an excess of an aryloxyalkanol in the presence of a condensation catalyst to produce an intermediate mixture comprising a bis(aryloxyalkyl)terephthalate, a mono(aryloxyalkyl)terephthalate, and unreacted aryloxyalkanol. This mixture continues to react at reduced pressure while unreacted aryloxyalkanol is removed and the mono-ester content is reduced to less than 1 mole % based on the combined amounts of mono- and bis-esters. Both steps are performed substantially in the absence of oxygen. Additional unreacted aryloxyalkanol is then removed to provide a purified bis(aryloxyalkyl)terephthalate having an overall purity of at least 98 mole % and a yellowness index less than 10. Careful control over catalysis, exposure to air, and other process conditions enables the preparation of high yields of bis(aryloxyalkyl)terephthalates that have low color and other valuable attributes. A method of producing bis(aryloxyalkyl)terephthalate articles having improved compressive strength is also disclosed. | 2014-06-05 |
| 20140155532 | CURED PERFLUOROELASTOMER ARTICLE - Cured perfluoroelastomers that contain high levels (i.e. greater than 50 phr) BaSO | 2014-06-05 |
| 20140155533 | NANO-SIZED COMPOSITES CONTAINING POLYVINYL PYRROLIDONE MODIFIED SODIUM SILICATES AND METHOD FOR MAKING BINDERS USING SAME - This invention provides a method to form nano-sized dispersed structure consisting of aqueous sodium silicate and polyvinyl pyrrolidone (PVP) solutions, and a binder consisting of a nano-sized dispersed structure and calcium chloride dihydrate solution. The invention provides also a method to immobilize sand dunes and wind-blown dust by using the binder. | 2014-06-05 |
| 20140155534 | RESIN COMPOSITION AND MOLDED ARTICLE COMPOSED OF THE SAME - A resin composition comprising a polylactic acid-based resin (A) and methacrylic resins (B), wherein the methacrylic resins having at least (a) a difference of 10° C. or more in glass transition temperature or (b) a difference of 3% or more in syndiotacticity; it is preferred that at least one of the methacrylic resins (B) is a methacrylic resin having a weight average molecular weight of 50,000 to 450,000, a glass transition temperature of 110° C. or higher and a syndiotacticity of 40% or more, and that the resin composition further contains a multilayer structure polymer formed as particles each consisting of a core layer and one or more shell layers covering it (C). A molded article made of said resin composition. | 2014-06-05 |
| 20140155535 | METHOD OF PREPARING ENCAPSULATED PIGMENT DISPERSIONS WITH MINIMAL FREE POLYMER - A process for encapsulating pigment dispersions is provided where a pigment is dispersed with a polymeric dispersant in an aqueous solvent system. The free polymer dispersant in the pigment dispersion is limited to less than 0.12 grams per gram of pigment. This dispersed pigment is then encapsulated by adding acrylate monomers and optionally acrylic and vinyl monomers and polymerizing. In the encapsulated pigment dispersion the weight ratio of final free polymer to polymer found to the final encapsulated pigment is less than 0.9. The free polymer dispersant is measured by a centrifugation method and the final free polymer is measured by a density gradient centrifugation method. Such encapsulated pigment dispersions may be used in inkjet inks and are stable to heat, aging test conditions, and solvent challenges. Prints from these inks have better durability. | 2014-06-05 |
| 20140155536 | RUBBER COMPOSITION AND TIRE - The present invention relates to a rubber composition including (A) at least one rubber component selected from the group consisting of a synthetic rubber and a natural rubber; (B) a polymer of farnesene having a weight-average molecular weight of not less than 2,000 and less than 25,000; and (C) carbon black. | 2014-06-05 |
| 20140155537 | HEAT RESISTANT HYDROCARBON ELASTOMER COMPOSITIONS - Disclosed herein is a curable composition comprising ethylene copolymer elastomer, a relatively small amount of a polyamide, and optionally a compatibilizer wherein curable composition demonstrates improved heat aging properties without the loss of tensile strength. Also disclosed is the process for making such curable ethylene copolymer elastomer. | 2014-06-05 |
| 20140155538 | HEAT RESISTANT HYDROCARBON ELASTOMER COMPOSITIONS - Disclosed herein is a polyamide-filled curable hydrocarbon elastomer compositions having enhanced heat aging performance where the presence of conventional filler, such as carbon black or silica, does not detract from desired heat stability properties. Also disclosed are polyamide-filled curable hydrocarbon elastomer compositions where the use of compatibilzer is optional, for polyamides having an inherent viscosity of greater than 0.88 dL/g. | 2014-06-05 |
| 20140155539 | RUBBER COMPOSITION FOR TIRES, AND PNEUMATIC TIRE - The invention provides a rubber composition for tires, enabling a balanced improvement of processability, rubber strength, fuel economy, and crack growth resistance; and a pneumatic tire formed from the rubber composition. The invention relates to a rubber composition for tires, including: a butadiene rubber (a) having a cis content of 96% by mass or more, a Mooney viscosity of 35 to 75, and a ratio of (Weight average molecular weight (Mw))/(Number average molecular weight (Mn)) of 2.7 or less; and a butadiene rubber (b) containing 1,2-syndiotactic polybutadiene crystals with a melting point of 90 to 140° C., and having a weight average molecular weight of 50,000 to 500,000. | 2014-06-05 |
| 20140155540 | MOLDING MATERIAL, MOLDING METHOD USING SAME, METHOD FOR PRODUCING MOLDING MATERIAL, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL - Provided is a molding material comprising a composite of 1 to 50 wt % of a continuous reinforcing fiber bundle (A) and 0.1 to 20 wt % of a poly(phenylene ether ether ketone) oligomer (B); and 30 to 98.9 wt % of a thermoplastic resin (C) adhering to the composite, wherein the component (B) has a melting point of not higher than 270° C. Also provided are a method for molding the molding material, a method for producing the molding material, and a method for producing a fiber-reinforced composite material. | 2014-06-05 |
| 20140155541 | COUPLING AGENT FOR RUBBER/CARBON BLACK, AND RUBBER COMPOSITION CONTAINING SAME FOR USE IN TIRES - The present invention relates to a coupling agent for rubber/carbon black, containing a sulfide compound represented by the following chemical formula (I): | 2014-06-05 |
| 20140155542 | PREPARATION AND USE OF FUNCTIONALIZED ELASTOMERS IN RUBBER COMPOSITIONS CONTAINING SILICA FILLER AND TIRE COMPONENTS THEREOF - This invention relates to preparation and use of in situ functionalized elastomers in a rubber composition, namely post polymerization functionalization of elastomers, in rubber compositions containing precipitated silica filler reinforcement and tires having components thereof. | 2014-06-05 |
| 20140155543 | PROCESS FOR THE PREPARATION OF 1,3-BUTADIENE AND STYRENE COPOLYMERS AND USE THEREOF IN VULCANIZABLE ELASTOMERIC COMPOSITIONS - A process for the preparation of a 1,3-butadiene and styrene copolymer comprising the following steps: a) anionically polymerizing a blend comprising from 5% by weight to 40% by weight of styrene and from 60% by weight to 95% by weight of 1,3-butadiene, with respect to the overall weight of the mixture, in the presence of at least one hydrocarbon solvent, of at least one lithium-based catalyst having the general formula LiR | 2014-06-05 |
| 20140155544 | TIRE WITH COMPONENT COMPRISED OF RUBBER COMPOSITION CONTAINING SILICA AND GRAPHENE PLATELET REINFORCEMENT - This invention relates to a rubber composition comprised of diene-based elastomer, precipitated silica and nano-scale exfoliated graphene platelets. A tire is provided having a component comprised of such rubber composition. | 2014-06-05 |
| 20140155545 | CROSS-LINKABLE MATERIALS BASED ON ORGANYL OXYSILANE-TERMINATED POLYMERS - Moisture curable adhesives of high tensile shear strength contain an alkoxysilyl-terminated polymer and an alkoxy-functional silicone resin. | 2014-06-05 |
| 20140155546 | POLYIMIDE PRECURSOR, POLYIMIDE, AND COATING SOLUTION FOR UNDER LAYER FILM FOR IMAGE FORMATION - There is provided a polyimide precursor which can alter the hydrophilicity/hydrophobicity of the surface of a cured film formed readily even by a low level of ultraviolet ray irradiation; and a polyimide produced from the polyimide precursor. The polyimide precursor having a structure represented by the following formula (1): | 2014-06-05 |
| 20140155547 | UNORIENTED FILM - Unoriented film comprising at least 70 wt.-% of an heterophasic propylene copolymer, said heterophasic propylene copolymer comprises a matrix being a random propylene copolymer and an elastomeric propylene copolymer dispersed in said matrix, wherein the heterophasic propylene copolymer has (a) a melt flow rate MFR | 2014-06-05 |
| 20140155548 | AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE FORMED THEREFROM - To provide an aromatic polycarbonate resin composition which has an impact resistance improved by blending of an impact strength improver and which also has an excellent transparency and a good surface hardness. The aromatic polycarbonate resin composition includes, with respect to 100 parts by mass of a resin component containing 55 to 85 percent by mass of an aromatic polycarbonate resin (A) having a mass average molecular weight of 15,000 to 40,000 and 15 to 45 percent by mass of a (meth)acrylate copolymer (B) which has a mass average molecular weight of 5,000 to 30,000 and which is composed of an aromatic (meth)acrylate unit (b1) and a methyl (meth)acrylate unit (b2) at a mass ratio (b1/b2) of 5 to 50/50 to 95, 1 to 20 parts by mass of an impact strength improver (C). A refractive index nab of the resin component at a wavelength of 589 nm and a refractive index nc of the impact strength improver (C) at a wavelength of 589 nm satisfy the following formula i). | 2014-06-05 |
| 20140155549 | CHEMICAL RESISTANT AND FIRE RETARDANT POLYCARBONATE POLYESTER COMPOSITION - A composition comprising a blend of: a) one or more polycarbonates; b) one or more polyesters; c) one or more core shell rubbers having glycidyl groups on the surface of the core; and d) one or more halogenated fire retardant agent; wherein the polycarbonates and polyesters form separate phases and the core shell rubber is located in the polyester phase. The compositions may further comprise a fluoropolymer capable of functioning as an anti-drip agent. The compositions exhibit a flame retardant rating according to UL-94 at V-0 of 3.0 mm or less; a notched Izod impact strength of about 8 foot pounds per inch or greater (0.90 joules) and chemical resistance to one or more of the common cleaning compositions selected from bleach, polyethylene glycol, a mixture of aryl substituted phenols and aryl substituted chlorophenols, a mixture of an alkanol and a monoalkyl ether of ethylene glycol, and one or more ammonium chlorides. | 2014-06-05 |
| 20140155550 | THERMOPLASTIC ELASTOMER COMPOSITION - A thermoplastic elastomer composition is free from halogens such as bromine, and is comparable or superior in tensile characteristic to a conventional thermoplastic elastomer composition containing a brominated alkylphenol formaldehyde resin as a crosslinking agent. The composition contains an EPDM containing 5-ethylidene-2-norbornene as a diene component, 75 to 300 mass % of an alkylphenol formaldehyde resin having methylol groups at opposite molecular terminals thereof as a crosslinking agent based on the diene amount of the EPDM, 0.7 to 3 mass % of a strong Bronsted acid as a catalyst based on the amount of the alkylphenol formaldehyde resin, and a thermoplastic resin. | 2014-06-05 |
| 20140155551 | PEROXIDE CURABLE FLUOROELASTOMER COMPOSITIONS - Disclosed herein is a curable composition comprising a peroxide curable fluoroelastomer, an organic peroxide, a multifunctional coagent and a polyamide. Such curable compositions cure to a high degree in a short time. | 2014-06-05 |
| 20140155552 | HEAT AGING RESISTANT ETHYLENE VINYL ACETATE COPOLYMER COMPOSITION AND PROCESS FOR ITS PRODUCTION - Heat resistant ethylene vinyl acetate copolymer compositions comprising a blend of ethylene vinyl acetate copolymer, peroxide curable polyacrylate elastomer, and polyamide are described. When crosslinked with a peroxide curative, the ethylene vinyl acetate copolymer compositions exhibit enhanced resistance to heat aging compared to conventional ethylene vinyl acetate elastomer compositions. | 2014-06-05 |
| 20140155553 | HDPE Modified Polyethylene Blown Film Compositions Having Excellent Bubble Stability - The present invention relates to polyethylene compositions comprising one or more ethylene polymers and one or more HDPE modifiers, in particular, this invention further relates to polyethylene blends comprising one or more ethylene polymers and one or more HDPE modifiers, wherein the modifier has: 1) a density of greater than 0.94 g/cc; 2) a M | 2014-06-05 |
| 20140155554 | POLYPROPYLENE COMPOSITION - A polyolefin composition comprising (percent by weight):
| 2014-06-05 |
| 20140155555 | Molecularly Imprinted Polymers Selective for Tobacco Specific Nitrosamines and Methods of Using Same - A class of molecularly imprinted polymers that specifically recognizes and binds to TSNAs are useful, for example, in analysis and separation of TSNAs from biological fluids. Such polymers are also useful in methods of treating and manufacturing tobacco products and materials. | 2014-06-05 |
| 20140155556 | ADHESIVE SYSTEMS USING IMINES AND SALTS THEREOF, PRECURSORS TO ELECTRON DEFICIENT OLEFINS AND COREACTANTS THEREFOR - This invention relates to adhesive systems using imines and salts thereof, precursors to electron deficient olefins and coreactants therefor. | 2014-06-05 |
| 20140155557 | NOVEL DURABLE, HYDROLYSIS-STABLE BIO-BASED PLASTICS BASED ON POLYHYDROXYALKANOATE (PHA), METHOD FOR PRODUCING SAME, AND USE THEREOF - The invention relates to the invention provides innovative long-lived and hydrolysis-stable biobased plastics based on polyhydroxyalkanoate (PHA) and featuring sufficient melt stability, a method for producing them and their use. | 2014-06-05 |
| 20140155558 | OXAZOLIDONE RING CONTAINING VINYL ESTER RESIN AND PRODUCTS THEREFROM - A process comprising contacting a) an epoxy resin; b) an adduct comprising at least one oxazolidone ring prepared from a multifunctional epoxy resin and an isocyanate compound; and c) an unsaturated acid to form a vinyl ester, is disclosed. | 2014-06-05 |
| 20140155559 | METHOD FOR PRODUCING POLYETHER POLYOLS - The present invention relates to a process for the preparation of polyether carbonate polyols from one or more H-functional starter compounds, one or more alkylene oxides and carbon dioxide in the presence of a double metal cyanide catalyst, wherein (α) the H-functional starter substance or a mixture of at least two H-functional starter substances is initially introduced into the reaction vessel, (β) for the activation, a part amount (based on the total amount of the amount of alkylene oxides employed in steps (β) and (γ)) of one or more alkylene oxides is added to the mixture resulting from step (α), it also being possible for step (β) to be carried out several times for the activation, (γ) one or more alkylene oxides and carbon dioxide are metered continuously into the mixture resulting from step (β) (“copolymerization”), the alkylene oxides employed for the copolymerization being identical to or different from the alkylene oxides employed in step (β), characterized in that in step (γ) the carbon dioxide is passed into the mixture by (i) gassing the reaction mixture in the reactor from the bottom, (ii) using a hollow shaft stirrer, (iii) a combination of the metering operations according to (i) and (ii), and/or (iv) gassing over the surface of the liquid by using stirrer units configured in several stages. | 2014-06-05 |
